Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model

Fig. 5

CCL1 blockade reduced Th2-related chemokine expression as well as eosinophil infiltration. a Level of mRNA for CCL1, CCL17, and CCL22 in the lungs and skin on day 20. b Eosinophil peroxidase (EPX) immunohistochemical staining was quantified on day 20. Original magnification, × 200. c IgE production in the lungs and skin on day 20. Each value indicates the mean ± SEM of 4–9 mice per group. *P < 0.05; **P < 0.01, ***P < 0.001

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512